Glutamate dehydrogenase mutant and application thereof
US-11339380-B2 · May 24, 2022 · US
US11781117B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11781117-B2 |
| Application number | US-202117505945-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 20, 2021 |
| Priority date | Dec 31, 2020 |
| Publication date | Oct 10, 2023 |
| Grant date | Oct 10, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed are a machine learning gene mining method and a phosphinothricin dehydrogenase mutant for amino translocation. The phosphinothricin dehydrogenase mutant for amino translocation is obtained by mutation of a wild-type phosphinothricin dehydrogenase with an amino acid sequence as shown in SEQ ID No.2 at one of the following sites: (1) E263D-K134R-H96A-R290V; (2) E263D-K134R-H96A; (3) E263D-K134R; (4) E263D; (5) E263N; (6) E263C; and (7) E263G. The present invention utilizes the site-saturation mutagenesis technology to mutate a phosphinothricin dehydrogenase gene as shown in SEQ ID No. 1, finds that the 263rd, 134th, 290th and 290th positions are the key sites affecting enzyme activity and stereoselectivity, and obtains a mutant with enzyme activity and ee value much higher than those of the parent phosphinothricin dehydrogenase.
Opening claim text (preview).
What is claimed is: 1. A phosphinothricin dehydrogenase mutant for amino translocation with the amino acid sequence of wild-type phosphinothricin dehydrogenase from Pseudomonas hunanensis as shown in SEQ ID NO: 2 except having one of the following sites of mutation: (1) E263D-K134R-H96A-R290V; (2) E263D-K134R-H96A; (3) E263D-K134R; (4) E263D; (5) E263N; (6) E263C; or (7) E263G. 2. A gene encoding the phosphinothricin dehydrogenase mutant for amino translocation according to claim 1 . 3. A genetically recombinant bacterium comprising a host cell and a target gene transformed into the host cell, wherein the target gene comprises the gene according to claim 2 . 4. The genetically recombinant bacterium according to claim 3 , wherein the genetically recombinant bacterium further comprises a gene encoding a glucose dehydrogenase transformed into the host cell. 5. The phosphinothricin dehydrogenase mutant for amino translocation according to claim 1 , wherein the site of mutation is: E263D-K134R-H96A-R290V. 6. A method for preparing L-phosphinothricin, by reacting 2-carbonyl-4-(hydroxymethylphosphono)butyric acid as a substrate as catalyzed by a catalyst in the presence of an inorganic amino donor, a coenzyme circulation system and a corresponding co-substrate of the coenzyme circulation system to obtain L-phosphinothricin; wherein the catalyst is one of: (1) the phosphinothricin dehydrogenase mutant for amino translocation according to claim 1 ; and (2) a genetically recombinant bacterium producing the phosphinothricin dehydrogenase mutant for amino translocation according to claim 1 , or a crude enzyme liquid containing the phosphinothricin dehydrogenase mutant obtained by lysis of the genetically recombinant bacterium. 7. The method according to claim 6 , wherein the coenzyme circulation system is at least one of: (1) a formate dehydrogenase coenzyme circulation system comprising a formate dehydrogenase, formate and a coenzyme; (2) a glucose dehydrogenase coenzyme circulation system comprising a glucose dehydrogenase, glucose and a coenzyme; and (3) an alcohol dehydrogenase coenzyme circulation system comprising an alcohol dehydrogenase, isopropanol and a coenzyme. 8. The method according to claim 7 , wherein the coenzyme circulation system is a formate dehydrogenase coenzyme circulation system comprising a formate dehydrogenase, formate and a coenzyme.
with NAD or NADP as acceptor (1.4.1) · CPC title
acting on CH-OH groups as donors (1.1) · CPC title
Alpha- or beta- amino acids {(other amino acids C12P13/005)} · CPC title
Sequence alignment; Homology search · CPC title
Glutamate dehydrogenase (1.4.1.2) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.